310 results on '"Altman, Douglas G"'
Search Results
2. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis
3. Taking healthcare interventions from trial to practice
4. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
5. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
6. Ten steps towards improving prognosis research
7. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers
8. The effects of excluding patients from the analysis in randomized controlled trials: meta-epidemiological study
9. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
10. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective cohort study
11. Prognosis and prognostic research: application and impact of prognostic models in clinical practice
12. Prognosis and prognostic research: what, why and how?
13. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
14. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews
15. Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years
16. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparisons of publications with protocols
17. Improving the reporting of pragmatic trials: an extension of the CONSORT statement
18. Composite outcomes in cardiovascular research: a survey of randomized trials
19. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
20. Extending the CONSORT Statement to randomized trials of nonpharmacologic treatment: explanation and elaboration
21. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots
22. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
23. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting
24. From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical Journal
25. The content of Medical Journal Instructions for Authors
26. Waiving confidentiality for the greater good
27. Reporting recommendations for tumor marker prognostic studies (REMARK)
28. Comparison of descriptions of allocation concealment in trial protocols and the published reports: Cohort study
29. Identifying outcome reporting bias in randomized trials on PubMed: Review of publications and survey of authors
30. Better reporting of harms in randomized trials: an extension of the CONSORT statement
31. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
32. CONSORT statement: extension to cluster randomised trials
33. Measuring inconsistency in meta-analyses
34. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. (Papers)
35. The landscape and lexicon of blinding in randomized trials
36. Reporting on statistical methods to adjust for confounding: a cross-sectional survey
37. Confidence intervals for the number needed to treat
38. Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units
39. The relation between treatment benefit and underlying risk in meta-analysis
40. Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors
41. Analysis of serial measurements in medical research
42. A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration
43. Indirect comparison meta-analysis of aspirin therapy after coronary surgery
44. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology
45. Commentary: prognostic models: clinically useful or quickly forgotten?
46. Completeness of reporting of randomised controlled trials including people with transient ischaemic attack or stroke: A systematic review
47. The STROBE Extensions
48. Concealing treatment allocation in randomised trials
49. Systematic reviews of evaluations of prognostic variables
50. Assessing the quality of controlled clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.